Researchers have discovered four critical genes linked to Pulmonary Arterial Hypertension (PAH), paving the way for ...

The global pulmonary arterial hypertension treatment market is on track to achieve significant growth over the next decade, with a projected valuation of USD 7,224.4 million by 2033. This expansion ...

Researchers studied 20 patients who were assigned to 12 weeks of supplemental oxygen for 16 or more hours a day or no oxygen ...

The Pulmonary Hypertension Association's "Let Your Light Shine" campaign ... The global PH community is encouraged to participate by advocating for better care and treatment access, volunteering to ...

PAH treatment Uptravi was effective for patients switching from other drugs and those with mental health conditions, ...

The Karnataka High Court has provided relief to court officer B Nagabhushana, allowing him reimbursement for medical expenses ...

One of the key highlights was the discussion of Pulmonary Embolism Response Teams (PERT), addressing controversies in PE management and focusing on personalized, patient-centered care.

Evidence suggests that patent ductus arteriosus comprises anywhere from 5% to 10% of all congenital heart disease.

A poster presented at the CHEST 2024 annual meeting shows that inhaled treprostinil (iTRE) reduces hospitalizations in ...

High blood pressure (hypertension) causes thickening of the blood vessels and hardening of the arteries (arteriosclerosis). A ...

Analyst Cory Jubinville, PhD from LifeSci Capital maintained a Buy rating on Liquidia Technologies (LQDA – Research Report) and keeping ...

Liquidia Technologies (LQDA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...